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Background: Postprandial metabolic and appetitive responses of proteins are dependent on protein source and
processing technique prior to ingestion. Studies on the postprandial effects of enzymatic crosslinking of milk
proteins are sparse. Our aim was to study the effect of transglutaminase (TG)-induced crosslinking of sodium
caseinate on postprandial metabolic and appetite responses. Whey protein was included as reference protein.
Methods: Thirteen healthy individuals (23.3 ± 1.1 y, BMI 21.7 ± 0.4 kg/m2) participated in a single-blind crossover
design experiment in which the subjects consumed three different isovolumic (500 g) pourable beverages
containing either sodium caseinate (Cas, 29 g), TG-treated sodium caseinate (Cas-TG, 29 g) or whey protein (Wh,
30 g) in a randomized order. Blood samples were collected at baseline and for 4 h postprandially for the
determination of plasma glucose, insulin and amino acid (AA) concentrations. Gastric emptying (GE) was measured
using the 13 C-breath test method. Appetite was assessed using visual analogue scales.
Results: All examined postprandial responses were comparable with Cas and Cas-TG. The protein type used in the
beverages was reflected as differences in plasma AA concentrations between Wh and Cas, but there were no
differences in plasma glucose or insulin responses. A tendency for faster GE rate after Wh was detected. Appetite
ratings or subsequent energy intake did not differ among the protein beverages.
Conclusions: Our results indicate that the metabolic responses of enzymatically crosslinked and native sodium
caseinate in a liquid matrix are comparable, suggesting similar digestion and absorption rates and first pass
metabolism despite the structural modification of Cas-TG.
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Food digestion is affected by the characteristics of
macronutrients as well as by the micro- and macrostruc-
ture of the food, which may have pronounced effects on
subsequent metabolic and appetitive responses [1-6].
Despite the progress in our understanding of the regula-
tion of postprandial metabolism and energy homeostasis,
attempts to influence physiological mechanisms and* Correspondence: kristiina.juvonen@uef.fi
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reproduction in any medium, provided the orenergy balance by altering the structural characteristics
of foods have been modest.
Modification with crosslinking enzymes such as trans-
glutaminase (TG) has been used extensively to change
the functionality of proteins and thereby to improve the
textural quality and stability of protein-based food pro-
ducts [7]. In dairy products, TG-induced crosslinking
can increase the firmness and water-holding capacity of
acid-induced gels in products with low solids and fat
content or to improve the stability of emulsions and
foams [8]. Despite the evidence on the benefits of TG-
induced crosslinking in milk protein-based products, we
are still a long way from fully understanding its effects
on protein digestion in the gastrointestinal (GI) tract.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Participant characteristics*
Characteristic Value SEM
Age (years) 23.3 1.1
Weight (kg) 62.8 2.3
Height (m) 1.70 0.02
Body mass index (kg/m2) 21.7 0.4
Systolic blood pressure (mm Hg) 116.0 2.9
Diastolic blood pressure (mm Hg) 72.2 1.9
Oral-glucose-tolerance
Plasma glucose, 0 min (mmol/l) 5.3 0.1
Plasma glucose, 120 min (mmol/l) 5.2 0.3
Three-Factor Eating Questionnaire
- cognitive restraint of eating (factor 1) 8.9 1.2
- disinhibition (factor 2) 4.8 0.6
- hunger (factor 3) 4.1 0.6
*Mean values with their standard errors, n 13 (11 female, 2 male).
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with TG renders casein more resistant to proteolysis by
pepsin and trypsin [9,10], but the results have not been
confirmed in humans. Since TG action results in cross-
links between glutamine and lysine residues in proteins,
some concern has been raised over the bioavailability of
lysine in TG-treated products. In animal studies (rats),
however, the isopeptide bond formed by TG between
glutamine and lysine residues appears to be cleaved by
enzymes present in the GI tract or kidneys [11,12]. Roos
et al. [13] reported that crosslinking of casein with TG
does not inhibit proteolysis in vitro or digestibility in the
intestinal tract of miniature pigs when fed as part of a
mixed diet.
Whey protein has been described as a “fast” soluble
protein after which gastric emptying (GE) is rapid and
the postingestive amino acid (AA) response high, fast
and transient. In contrast, the “slow” casein protein pre-
cipitates at the low pH prevailing in the stomach, result-
ing in a delayed GE rate and a lower, slower and
prolonged AA response [14,15]. However, TG-crosslinking
may change casein’s clotting behaviour in the stomach.
Flanangan et al. [16] showed that the solubility of
TG-treated sodium caseinate in water is improved at
pH-values between 2 and 6, which might result in a
higher digestion and GE rate. On the other hand, cross-
linking with TG results in stronger gels when a sodium
caseinate solution is slowly acidified to pH 4.6 [17],
which might delay digestion and GE. Also other factors
than pH, such as meal dilution [18] and components ei-
ther from the food or gastric juice need to be taken into
account when considering the behaviour of proteins in
the stomach. NaCl, for instance, is known to limit the
solubility of TG-treated sodium caseinate to a great ex-
tent at pH 3.2 [19].
We recently found that TG-induced crosslinking of so-
dium caseinate modified both postprandial appetite and
metabolic responses [20] after a test meal with a rather
high protein concentration (13%), where the TG treatment
changed the form of the test product from a high-viscous
liquid to a strong gel. The altered responses might thus
not only be the result of the crosslinking per se, but the
difference in the form of the test products might also play
an important role. Therefore, to better understand the
postmeal effects of protein crosslinking, we investigated
the effect of TG-induced crosslinking of sodium caseinate
on postprandial metabolic and appetitive responses in
healthy young individuals using test products with less
pronounced differences in rheological properties. By low-
ering the protein content to 6%, pourable model beverages
could be prepared both with and without TG treatment.
Non-crosslinked whey protein was included as reference
protein. We hypothesized that crosslinking of sodium
caseinate could alter its clotting behaviour in the stomachand thereby affect the rates of digestion and gastric empty-
ing, which could result in changes in subsequent post-
prandial responses of plasma glucose, insulin and amino
acids as well as appetite ratings.Methods
Subjects
A total of 13 healthy normal-weight individuals (11 fe-
male, 2 male) were recruited via an intranet announce-
ment to participate in a study at the Department of
Clinical Nutrition at the University of Eastern Finland
(Table 1).
During the screening phase volunteers were interviewed
about their medical history, dietary habits and physical ac-
tivity. Individuals were excluded if they had any allergies
or food intolerances, did not eat breakfast, had modified
their diet or exercise patterns during the past year to lose
weight, were taking medication (except oral contracep-
tives) or were smokers. The Three-Factor Eating Ques-
tionnaire (TFEQ) [21] was used to exclude subjects with
abnormal eating behavior. All participants had normal
glucose tolerance (fasting plasma glucose ≤5.7 mmol/l and
2-h glucose <7.8 mmol/l) determined by the oral glucose
tolerance test (OGTT). Participants were individually
familiarized with the study procedures and measurements
prior to the actual study visits to reduce potential con-
founding factors due to misunderstanding.
This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all proce-
dures involving human subjects were approved by the
Ethics Committee of the University of Kuopio and Kuo-
pio University Hospital. Written informed consent was
obtained from all subjects.
Table 2 Ingredients used in the test beverages
(g/portion)
Cas Cas-TG Wh
Protein powder (g) 33.15* 34.05† 32.26{
Glucose (g)} 40.0 40.0 40.0
Aroma (g)|| 4.0 4.0 4.0
13 C acetic acid (mg)} 50 50 50
Water up to 500 g
Cas, caseinate; Cas-TG, transglutaminase treated Cas; Wh, whey protein.
*Non-enzyme-treated sodium caseinate powder prepared for the study,
composition: 86.3% protein from sodium caseinate, 6.1%
maltodextrin + lactose (from TG and sodium caseinate powder), 3.8% ash, 2.9%
moisture, 0.8% fat, 0.06% TG-enzyme (inactivated), DMV International, Veghel,
The Netherlands.
†TG-treated sodium caseinate powder prepared for the study, composition:
84.0% sodium caseinate, 5.0% maltodextrin + lactose (from TG powder), 5.5%
moisture, 3.7% ash, 0.8% fat, 0.06% TG-enzyme.
{Whey protein isolate (mainly beta-lactoglobulin), BiPROW, composition: 92.9%
protein, 5% moisture, 1.9% ash, 0.4% fat and 0.5% lactose, Davisco Foods
International, Inc., USA.
}Anhydrous glucose, composition 100% dextrose anhydre CF, moisture 0.5%,
Oriola, Espoo, Finland.
||Orange aroma, Spice Aroma Finland Ky, Kuopio, Finland.
}13 C labeled acetic acid for measuring gastric emptying, Wagner Analysen
Technik GmbH, Bremen, Germany.
Table 3 Composition of test beverages*
Cas Cas-TG Wh
Portion size (g) 500 500 500
Energy (kJ (kcal)) 1194 (281) 1172 (276) 1163 (274)
Energy density (kJ/g) 2.39 2.34 2.33
Protein (g (E%†)) 28.6 (41) 28.6 (41) 30.0 (44)
Carbohydrates (g (E%†)) 41.0 (58) 39.7 (58) 38.2 (56)
Fat (g (E%†)) 0.3 (1) 0.3 (1) 0.1 (0)
Cas, caseinate; Cas-TG, transglutaminase treated Cas; Wh, whey protein.
†Percentages of total energy content.
*Ingested with 100 ml of water.
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products
A batch of TG-treated sodium caseinate powder was
prepared for the study. A non-enzyme-treated reference
material was prepared as well. Sodium caseinate (EM7)
from DMW International (The Netherlands), composed
of 90% protein, 5% moisture, 4% ash, 0.8% fat and 0.2%
lactose, was used as the casein source. TG powder
(Activa MP) from Ajinomoto Foods Europe SAS
(France), consisting of 94% maltodextrin + lactose, 5%
moisture and 1% protein, was used as the crosslinking en-
zyme. TheTG activity of the powder was determined using
0.03 MN-carbobenzoxy-L-glutaminyl-glycine (Sigma) as
the substrate at pH 6.0 according to Folk [22]. For the
TG powder an activity of 2600 nkat/g was measured. A
single nanokatal (nkat) is defined as the amount of en-
zyme activity that converts 1 nmol/s of the substrate
used in the assay conditions.
Powders were prepared by mixing 1169 g sodium case-
inate with 9000 g cold tap water in a Diosna spiral mixer
(SP 24 F/E, Dierks & Söhne GmbH, Germany). After ini-
tial mixing, 8000 g of water heated to 90 °C was added,
and mixing continued until a homogeneous solution was
obtained. The protein content of the solution was ap-
proximately 5.5% at this point. The sodium caseinate so-
lution was poured into a 40 litre fermenter (IF 40, New
Brunswick Scientific, USA) and warmed up to 40 °C
under gentle stirring (50 rpm). A 10% suspension of TG
in water was prepared and 754 g of the suspension was
added to the sodium caseinate solution, which corre-
sponds to 200 nkat TG per g sodium caseinate. The so-
dium caseinate content of the mixture was adjusted to
5% by adding the required amount of water. The mix-
ture was incubated for 2 h at 40 °C for the transglutami-
nase reaction and then heated at 90 °C for 15 min to
inactivate the enzyme, cooled, frozen at −20 °C and
freeze-dried. The non-enzyme-treated reference powder
was prepared according to the same protocol, but the
TG suspension was heated for 5 min in a boiling water
bath (to inactivate the enzyme) prior to adding it to the
sodium caseinate solution. The microbiological quality
of the test powders fulfilled the regulatory requirements
set for milk powders.
Test products
A total of three isoenergetic and isovolumic dairy pro-
tein based beverages containing a) untreated sodium
caseinate (Cas), b) transglutaminase-treated sodium
caseinate (Cas-TG) and c) untreated whey protein (Wh),
were served as test products. The used ingredients and
detailed composition of the test products are shown in
Tables 2 and 3, respectively. Whey protein was included
as a reference product due to the previously demon-
strated distinct postprandial effects of whey protein ascompared to casein [14,23,24]. Furthermore, beverage
portions contained 40 g of glucose to stimulate glucose-
dependent postprandial responses and to mimic the nu-
tritional composition of a mixed diet.
The test beverages were prepared by dissolving the an-
hydrous glucose powder in water. Then the protein pow-
der was added to the glucose solution and stirred until
completely dissolved. The test beverages were stored in
the refrigerator (5 °C) overnight covered with plastic
film. In the morning of the test day the volume of the
test beverages was leveled up to 500 g with water, and a
natural orange aroma and 13 C acetic acid as a marker
for gastric emptying were added to each test beverage
just before serving.Characterization of the test products
The level of protein crosslinking of the sodium caseinate
powders was analysed by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) as described
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shown in Figure 1A, extensively crosslinked in compari-
son with the non-enzyme-treated powder. Ercili Cura
et al. [17] showed that even a lower level of sodium
caseinate crosslinking resulted in marked changes in
rheological properties and microstructure of gels pro-
duced by acidification to pH 4.6.
The viscosity of the test products was measured at
20 °C with a stress controlled rotational rheometer (AR-
G2, TA Instruments, UK) equipped with a concentric cy-
linder geometry (diameter of cup and bob 30 and
28 mm, respectively). After loading the samples to the
measuring geometry, they were allowed to rest for 5 min
before the measurement was started. The steady-state
viscosity of the samples was measured in duplicate with
a gradually increasing shear stress with values resulting
in shear rates in the range 0.1-500 s-1.
The test product prepared from the crosslinked so-
dium caseinate powder showed a higher viscosity thanFigure 1 (A) SDS-PAGE-analysis of sodium caseinate powders prepare
2) sodium caseinate crosslinked with transglutaminase. (B) Viscosity of test
replicate measurements are shown, caseinate (−−○−−), transglutaminase-tthe ones prepared from non-crossliked sodium caseinate
or whey protein (Figure 1B), but all test products still
remained pourable, in contrast to our previous study
[20], in which crosslinking with TG resulted in the for-
mation of a very rigid gel.
Study design
Each subject participated in the study with a single-
blind, randomized, crossover design where all partici-
pants tested each beverage with more than 2 d between
the tests. The subjects were instructed to maintain their
habitual diet and exercise routines as constant as pos-
sible, refrain from heavy exercise on the day before the
study visit and avoid alcohol consumption for 2 d before
the test day. Subjects were requested to arrive to each la-
boratory visit the same way (e.g. walking, cycling, car or
bus) and to avoid extra physical stress before the begin-
ning of the visit. At the beginning of each experi-
ment the participants were weighed and their alcohold for the study. Lane 1) non-enzyme-treated sodium caseinate, lane
products as function of shear rate. For each sample, the results of two
reated caseinate (−●–) or whey protein (4).
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vious day were checked by an interview.
All the study visits began in the morning after a 10–
12 h fast. During the first study visit oral glucose toler-
ance test (OGTT, 75 g glucose dissolved in 300 ml
water), was performed to ascertain normal glucose toler-
ance. The OGTT procedure had otherwise exactly the
same study protocol as the following three study ses-
sions to familiarize the subjects with the study protocol
and measures. During the actual study visits, subjects
consumed one of the chilled test beverages between
07.45–08.15 hours along with 100 ml of tap water in a
randomized order: a beverage containing either (1) un-
treated sodium caseinate, (2) transglutaminase (TG)
treated sodium caseinate or (3) whey protein isolate
(Table 2 and 3).
Blood samples were taken for the determination of
plasma glucose, insulin, and amino acid concentrations
via an indwelling cannula placed in the forearm 10 min
prior to the first blood sampling. Venous samples were
collected at baseline and 15, 30, 45, 60, 90, 120, 180 and
240 min after the ingestion of the test beverages. Sub-
jects rated their appetite at the concomitant time points
immediately after the blood sampling in a separate
room. Breath test samples were collected immediately
before blood sampling at baseline and 15, 30, 45, 60, 75,
90, 105, 120, 150, 180, 210, 240 min after the test bever-
age consumption. Subjects were requested to avoid any
extra walking and stay in sitting position during the
study period to minimize the effects of body posture on
postprandial responses.
Appetite measurements
Appetite profile (hunger, satiety, desire to eat, fullness,
thirstiness), and pleasantness of the test meals were eval-
uated using Visual Analogue Scales (VAS). Each VAS
scale had 100 mm horizontal line with verbal anchors
(in Finnish) at either end expressing the weakest or
strongest statement (i.e. ‘I am not hungry at all’ or ‘I
have never been more hungry’). The participants were
advised to draw a vertical line on the horizontal axis cor-
responding to their sensations at the time of assessment.
VAS ratings were measured in millimeters, resulting in
scores between 0 and 100 for statistical analyses.
Food intake
Study participants were advised to keep detailed 24 h
food records to monitor their food intake during the
study. These included food records two days before each
study day, half-day record for the remaining day of each
experiment and the following day to reflect the baseline
diet and the effects of each test product on subsequent
food intake. The average daily energy and macronutrient
intake of the participants from the food records wereanalyzed by using the MICRO-NUTRICA database (ver-
sion 2.5; Finnish Social Insurance Institution, Turku,
Finland).
Biochemical measurements
Plasma samples for measurements of insulin and AA
were collected in prechilled EDTA-containing tubes and
fluoride citrate-containing tubes were used for plasma
glucose. Plasma insulin and AA samples were centri-
fuged within 15 min, for 15 min at 1700 x g at 4°C.
Plasma glucose samples were centrifuged for 10 min at
2400 x g at 4°C. All samples were immediately stored in
−70°C until analysed. Results were obtained from all the
study participants except for plasma AA measurements
for which 10 randomly selected individuals were
included.
Plasma glucose was analysed using an enzymatic
photometric assay (Konelab 20XTi Clinical Chemistry
Analyzer, Thermo Electron Corp, Vantaa, Finland) and
plasma insulin using a luminometric immunoassay
(ADVIA Centaur Immunoassay System, Siemens Med-
ical Solutions Diagnostics, Tarrytown, NY, USA). The
intra-assay CV for the plasma glucose was 2.7% at
10.2 mmol/l and the inter-assay CV was 4.1% at
2.05 mmol/l and 1.8% at 8.2 mmol/l. For plasma insulin,
the intra-assay CV was 2.7% at 667 pmol/l and the inter-
assay CV was 6.6% at 41 pmol/l and 5.1% at 444 pmol/l.
Plasma amino acid concentrations were analysed with
a Mass TRAKTM Amino Acid Analysis Application Solu-
tion (Waters). AccQ•Fluor reagent kit, Mass TRAKTM
Amino Acid Analysis concentrate A and eluent B were
obtained from Waters (Milford, MA, USA). Amino Acid
Standard Solution, Amino Acid Standards Physiological,
Basics, L-isoleusine and glutamine were obtained from
Sigma-Aldrich (St. Luis, Missouri, USA). A total volume
of 50 μl of sample was mixed with 200 μl of water and
50 μl of norvaline (0.025 mM) was added as an interval
standard. 300 μl of acetonitrile was added and after vor-
tex mixing the sample was filtrated through a sirocco
plate (Waters lot no 828001). Next, the extracts were
freeze-dried and reconstituted with 50 μl of water. Deri-
vatization was done with an AccQ•Fluor reagent kit.
AccQ•Fluor reagent was reconstituted with acetonitrile
(350 μl), vortexed for 10 seconds, heated at 55°C and
vortex until dissolved. AccQ•Fluor reagent (20 μl) was
added to 10 μl of the extract and 70 μl of boric acid buf-
fer, and the sample mixture instantly vortexed for 60
seconds. Samples were kept at 5 °C before and during
analysis. Analysis was performed on an Acquity UPLC
system (Waters, USA) with a diode array detector. Chro-
matography was performed using an Acquity Mass
TrakTM column (2.1 x 150 mm, 1.7 μm, (Waters Corpor-
ation, USA) kept at 43°C. The injection volume was
1.0 μl. Separation was performed using gradient elution
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water (A) and Amino Acid Analysis Eluent B (B) at a
flow rate of 0.4 ml/min. Signal was detected at 260 nm
(2.4 nm resolution, 20 points/second).
In addition to single amino acids, branched-chain
(BCAA; valine, isoleucine, leucine), essential (EAA; leu-
cine, isoleucine, valine, lysine/tyrosine (lysine and tyro-
sine concentrations counted up), phenylalanine,
threonine, tryptophan, arginine, histidine, cysteine) and
total plasma amino acid (TAA; glysine, alanine valine,
leucine, isoleucine, praline, phenylalanine, tryptophan,
serine, threonine, cysteine, methionine, arginine, histi-
dine, lysine/tyrosine, aspartic acid, glutamic acid, aspara-
gines, glutamine, ornithine, alpha amino-butyric acid,
citrulline, sarcosine, ethanolamine, carnosine, taurine, 1-
methyl-l-histidine, 3-methyl-l-histidine) concentrations
were summarized and included in the analyses.
Gastric emptying
Gastric emptying was assessed using the standardized
13 C-Acetate Breath Test -method in combination with
the quantitative isotope gas mixture analyser, IRIS 13 C-
Breath Test System (IRIS, non-dispersive infrared spec-
troscopy; Wagner Analysen Technik GmbH, Bremen,
Germany). GE is estimated by monitoring the appear-
ance of 13CO2 in breath test samples subsequent to con-
sumption and metabolism of 13 C-acetate labeled test
product adjusted by body weight and height of individ-
ual participants. Analysis of the 13CO2 appearance in the
samples provides estimates of individual GE parameters,
as described by the time with maximum speed of GE
after ingestion the test meal (tlag), the time when the first
half of the 13 C-labelled substrate dose of the test meal
has been metabolised (t1/2) and the GE coefficient
(GEC), which is a measure of initial gradient of GE.
Statistical methods
The data analyses were performed with SPSS for Win-
dows software (SPSS for WINDOWS, version 17.0,
USA). The results are expressed as mean and standard
error of the mean (SEM) with a value P ≤ 0.05 (2-sided)
as a criterion for the statistical significance.
Linear mixed-effects modelling was used to compare
the effects of the test meals on the postprandial meta-
bolic and appetite responses. In the analysis, the baseline
value of each parameter was used as a covariate to take
into account the possible effect of baseline differences
on the analysis. The method takes into account the
sources of variation where the subject is used as a ran-
dom factor and product, time and product x time as
fixed factors. Where a significant main effect of a prod-
uct, time or product x time interaction was observed
(P< 0.05), post-hoc analyses were performed using the
Bonferroni correction for multiple comparisons.Results
Plasma glucose and insulin responses
After all test beverages plasma glucose responses
increased initially from baseline up to 15 min, declined
thereafter towards the nadir at 90 min and returned
close to the baseline at 240 min (Figure 2A). Postmeal
insulin responses increased similarly after all test bev-
erages and peaked at 30 min after which the concentra-
tions returned towards the baseline (Figure 2B). No
significant differences were detected in postmeal glucose
and insulin responses between Cas and Cas-TG or be-
tween Cas/Cas-TG and Wh beverages (P> 0.05).
Plasma amino acid responses
Plasma amino acid profiles with significant differences
among the test products are shown in Figures 3 and 4.
No significant differences were detected between Cas
and Cas-TG in any of the postprandial amino acid con-
centrations. The concentrations of glutamic acid, lysine/
tyrosine, isoleucine, leucine and tryptophan were
increased more after whey protein than after Cas or
Cas-TG (Figure 3A–E). On the other hand, postprandial
concentrations of valine, histidine, phenylalanine and
proline were lower after whey protein than after Cas or
Cas-TG (Figure 3F–I).
Postprandial BCAA and EAA concentrations were
comparable between Cas and Cas-TG (P> 0.05). After
Wh BCAA and EAA concentrations were significantly
increased at 90 min when compared to Cas and Cas-TG
(P< 0.05) and at 120 min when compared to Cas-TG
(P< 0.05) (Figure 4A–C). No significant differences were
detected postprandially among the beverages in total AA
concentrations.
Gastric emptying
There were no significant differences in gastric half
emptying time (t1/2) and gastric emptying coefficient
(G.E.C.) among the test beverages (P> 0.05). The time
with maximum speed of GE after ingestion the test meal
(tlag) tended to differ between Cas and Wh so that the
time was greater for Cas than for Wh (P= 0.061) while
no difference was observed between Cas and Cas-TG.
Test product consumption and appetite ratings
The mean time for the consumption of the test products
was comparable: 2.2 (SEM 0.2) min for Cas, 2.1 (SEM
0.2) min for Cas-TG, and 2.2 (SEM 0.1) min for Wh.
All appetite responses varied significantly during the
experimental period (P< 0.05) (data not shown). Hun-
ger, desire to eat and thirst reached nadir at 15–30 min
and returned towards the baseline thereafter. Feelings of
satiety and fullness peaked at 15 min and gradually
declined towards the baseline values during the last
hours of the study period. No significant differences
Figure 2 Changes in the concentration of plasma glucose (A) and plasma insulin (B) during the 240 min postprandial period in young
individuals consuming beverages composed of caseinate (−−○−−), transglutaminase-treated caseinate (−●–) or whey protein (4).
Values are means ± SEM, n = 13.
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the test products.
Food consumption
Food consumption monitored by food diaries indicated
that energy intake and carbohydrate, fat and dietary fibre
consumption were comparable among the days before
each study day, the remaining day and the following day.
Dietary protein intake was greater after Cas-TG when
compared to Cas for the remaining of the study day
(84.9 vs. 65.5 g, P< 0.05). On the other days protein in-
take was comparable among the test products.
Discussion
We found that in healthy young women and men,
postprandial metabolic and appetitive responses werecomparable between the structurally modified and native
caseinate when consumed in the beverage form. This was
in contrast to our hypothesis that enzymatic crosslinking
of caseinate with TG would slow the GE rate with subse-
quent alterations in the postprandial responses of AA, glu-
cose and insulin. In line with earlier observations [23,25],
we found that Cas and Wh have protein-specific effects
on postprandial AA concentrations. Unlike some previous
reports [24,25], the different AA profiles were not
reflected in differences in postprandial responses related
to insulin and glucose metabolism or appetite responses.
This might partly be explained by the lower protein dos-
age, concentration and/or the carbohydrate source used in
our study. In our previous study [20], caseinate protein
was modified by intensive TG treatment, which induced
gel formation due to the high protein content (13%) of the
Figure 3 (See legend on next page.)
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Figure 3 Changes in the concentration of plasma glutamic acid (A), lysine/tyrosine (B), isoleucine (C), leucine (D), tryptophan (E),
histidine (F), valine (G), phenylalanine (H) and proline (I) during the 240 min postprandial period in young individuals consuming
beverages composed of caseinate (−−○−−), transglutaminase-treated caseinate (−●–) or whey protein (4). Values are means ± SEM,
n = 10, a) whey protein different from Cas-TG (P<0.05), b) whey protein different from Cas (P<0.05).
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and the physical form of the test product were changed.
The effects of this protein modification were reflected in
the postprandial appetite and metabolic responses so that
after the TG-treated solid caseinate test product fullness
was increased and glucose, insulin, glucagon-like peptide 1
and cholecystokinin responses were attenuated when com-
pared to liquid untreated caseinate and/or whey protein
test products [20]. In other studies the modification of the
form of the test foods has also been reflected in postpran-
dial metabolic and appetite responses [1,26-28], also with
foods containing only protein [6,29].
In this study, the protein content of the test products
was lowered to 6%, which resulted in a less pronounced
change in rheological properties of the test product
upon crosslinking as compared to our previous studyFigure 4 Changes in the concentration of plasma branched-chain am
amino acids (TAA) (C) during the 240 min postprandial period in you
(−−○−−), transglutaminase-treated caseinate (−●–) or whey protein (
Cas and Cas-TG (P< 0.05), b) whey protein different from Cas-TG (P< 0.05)[20]. The crosslinking-induced changes in the structure
and viscosity of the test product were not marked
enough to induce significant differences in the postpran-
dial responses. In other studies with various model
foods, differences in postprandial responses have been
observed among the test products in which the modifi-
cation process has been directed exclusively to the mo-
lecular level of the food components without remarkable
changes in the physical form of the test food [2-4,30].
These inconsistent results emphasize the importance of
better understanding the critical physiology- and food-
related aspects that modify postprandial GI functions,
such as the rate and extent of GE, digestion and absorp-
tion processes.
Hypothetically, TG-induced crosslinking of casein
could influence the digestive process in the upper GIino acids (BCAA) (A), essential amino acids (EAA) (B), and total
ng individuals consuming beverages composed of caseinate
4). Values are means ± SEM, n = 10, a) whey protein different from
.
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http://www.nutritionj.com/content/11/1/35tract through changes in its functional characteristics,
such as aggregation or gelation behaviour at the low pH-
values prevailing in the stomach, which may then affect
GE rate and subsequent postprandial glucose, insulin
and amino acid responses. Furthermore, altered physico-
chemical characteristic of the test products could also be
reflected in gastric function and appetite sensations
[31,32]. However, in the present study the TG-treatment
induced no significant effect on postingestive glucose,
insulin, AA or appetite responses. This may be because
of a low degree of crosslinking and/or low protein con-
centration in the test beverage, which nonetheless was
close to the protein concentration found in regular milk.
Fox et al. [33] used a comparable approach investigating
the effect of dephosphorylation of casein on gastric
emptying. Dephosphorylation was found to reduce the
size of aggregates formed under acid conditions and also
to increase the rate and extent of pepsin digestion of ca-
sein in vitro [34]. Such effects would be expected to in-
crease the rate of gastric emptying, but gastric emptying
tended to be faster for the unmodified than for the
dephosphorylated protein [33].
We included whey protein also in the study protocol
to verify the differences between the two main milk pro-
tein types, casein and whey protein. The most apparent
differences were detected in postprandial concentrations
of some plasma AAs, whereas glucose, insulin and appe-
tite responses and subsequent energy intake were similar
after these protein types. Several previous studies indi-
cate that casein and whey protein differ in their post-
prandial responses, especially in terms of GE rate [23],
insulin secretion [15,24], AA concentration [14,23,35],
and appetite responses [23,25]. However, there are also
earlier data supporting the results of the present study
showing that insulin [14,20,23,36-38] and appetite
responses [20] may not be affected by the different milk
protein types with protein-specific AA content. Surpris-
ingly, the results of a recent study by Acheson et al. [39]
showed that casein is more satiating than whey and GE
is faster after casein compared with whey protein, results
that partly challenge the findings of previous studies
[23,25]. These inconsistencies in the results on casein
and whey proteins in the short-term studies point out
the importance of the modulating effects of test product
-related factors, e.g. the dosage, concentration and type
of single protein used and presence or absence and
source of other macronutrients used in the test
products.
Comparable insulin profiles among our test products
were observed, despite the more pronounced postpran-
dial branched-chain amino acid (BCAA) concentrations
after Wh, which have been show to stimulate insulin se-
cretion [39]. We used glucose also in our test products
which certainly affected our insulin profiles to a higherextent than the BCAA. In studies where either lactose or
no additional carbohydrate was used in the test meals
different insulin responses between whey protein and ca-
sein were detected [15,24], but not always [36,37]. Fur-
thermore, Acheson et al. [39] who used dextrose in their
test products observed a more pronounced postprandial
insulin response after whey protein compared to casein.
However, unlike in our study the protein/carbohydrate
ratio in their study emphasized the protein content
which may have also affected the results. Therefore, the
additional glucose and the protein/glucose ratio in our
study resulted in pronounced postprandial insulinemia,
which masked the insulin-stimulating effects of insulino-
tropic AAs. The total plasma AA concentration is also
important for the insulin response as suggested by Nils-
son et al. [40] who showed that beverages that caused
the highest total postprandial AA increments caused
also the highest insulin responses. The total postprandial
AA response in our study was comparable among test
products as was the insulin response. Furthermore, the
form of test product [20] is adding to the complexity of
the metabolic system controlling overall homeostasis.
The trend for a faster GE after Wh than after Cas and
the differences in certain AA concentrations, especially
in the BCAA concentrations between Wh and Cas have
been demonstrated previously [23,24,35,37]. Our results
indicate that the milk proteins specifically modulate the
GE function. In addition to the potential effects of GE
rate on AA response, the differences in AA compositions
between the whey protein isolate and casein protein may
explain the differences in the postprandial plasma AA
responses, since milk protein-specific AA composition
appears to be reflected in the postprandial AA concen-
tration [41]. Furthermore, the type of casein (micellar
casein, sodium/calcium caseinate) is likely to add vari-
ation to the overall postprandial AA response profile
due to their potentially different postingestive behaviour
in the GI tract [42].Conclusions
Our study indicates that crosslinking with TG does not
alter postprandial metabolism and appetitive responses
of sodium caseinate when consumed in the form of a
pourable test products, even if crosslinking causes
changes in protein molecular structure and a slight in-
crease in the viscosity of the beverage. The changes
brought about by crosslinking were probably not exten-
sive enough to result in changes in postprandial gastric
functions or protein digestibility.
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